Breast-iRRISC: a novel model for predicting the individualised lifetime risk of radiation-induced breast cancer from a single screening event.
CONCLUSIONS: This unique tailored approach to risk assessment will further empower females and clinicians towards a more informed clinical decision process regarding future imaging pathways. It will also inform health policy decisions regarding alternate screening durations and intervals.
ADVANCES IN KNOWLEDGE: Breast-iRRISC is a novel tool that provides females, clinicians and health policymakers around the globe with the ability to quantify the lifetime risk of radiation-induced breast cancer from screening mammography on an individual level from a single exposure.
PMID: 33031706 [PubMed - as supplied by publisher]
Source: The British Journal of Radiology - Category: Radiology Authors: Hooshmand S, Reed WM, Suleiman ME, Brennan PC Tags: Br J Radiol Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Mammography | Radiology | UK Health | Wales Health